[HTML][HTML] Clinical utility of the pretreatment glasgow prognostic score in patients with advanced inoperable non-small cell lung cancer

EYL Leung, HR Scott, DC McMillan - Journal of Thoracic Oncology, 2012 - Elsevier
Introduction Traditional tumor-based staging systems provide limited information on the best
treatment option for individual patients with advanced inoperable non-small cell lung cancer …

Clinical utility of the pretreatment glasgow prognostic score in patients with advanced inoperable non-small cell lung cancer

EYL Leung, HR Scott, DC McMillan - Journal of Thoracic Oncology, 2012 - eprints.gla.ac.uk
Introduction: Traditional tumor-based staging systems provide limited information on the best
treatment option for individual patients with advanced inoperable non-small cell lung cancer …

Clinical utility of the pretreatment glasgow prognostic score in patients with advanced inoperable non-small cell lung cancer

EYL Leung, HR Scott… - Journal of thoracic …, 2012 - pubmed.ncbi.nlm.nih.gov
Introduction Traditional tumor-based staging systems provide limited information on the best
treatment option for individual patients with advanced inoperable non-small cell lung cancer …

[PDF][PDF] Clinical Utility of the Pretreatment Glasgow Prognostic Score in Patients with Advanced Inoperable Non-small Cell Lung Cancer

EYL Leung, HR Scott… - Journal of Thoracic …, 2012 - scholar.archive.org
Methods: The data of 261 patients with inoperable NSCLC were collected prospectively and
before treatment. Information on patient demographics, body mass index, performance …

[HTML][HTML] Clinical Utility of the Pretreatment Glasgow Prognostic Score in Patients with Advanced Inoperable Non-small Cell Lung Cancer

EYL Leung, HR Scott, DC McMillan - Journal of Thoracic Oncology, 2012 - jto.org
Introduction Traditional tumor-based staging systems provide limited information on the best
treatment option for individual patients with advanced inoperable non-small cell lung cancer …

[引用][C] Clinical Utility of the Pretreatment Glasgow Prognostic Score in Patients with Advanced Inoperable Non-small Cell Lung Cancer

EYL Leung, HR Scott, DC McMillan - Journal of Thoracic Oncology, 2012 - cir.nii.ac.jp
Clinical Utility of the Pretreatment Glasgow Prognostic Score in Patients with Advanced
Inoperable Non-small Cell Lung Cancer | CiNii Research CiNii 国立情報学研究所 学術情報 …

[引用][C] Clinical utility of the pretreatment glasgow prognostic score in patients with advanced inoperable non-small cell lung cancer.

EY Leung, HR Scott… - Journal of Thoracic …, 2012 - research.birmingham.ac.uk
Clinical utility of the pretreatment glasgow prognostic score in patients with advanced
inoperable non-small cell lung cancer. — University of Birmingham Skip to main navigation Skip …

[PDF][PDF] Clinical Utility of the Pretreatment Glasgow Prognostic Score in Patients with Advanced Inoperable Non-small Cell Lung Cancer

EYL Leung, HR Scott, DC McMillan - Journal of Thoracic Oncology, 2012 - core.ac.uk
Methods: The data of 261 patients with inoperable NSCLC were collected prospectively and
before treatment. Information on patient demographics, body mass index, performance …

Clinical utility of the pretreatment glasgow prognostic score in patients with advanced inoperable non-small cell lung cancer.

EY Leung, HR Scott, DC McMillan - … for the Study of Lung Cancer, 2012 - europepmc.org
Methods The data of 261 patients with inoperable NSCLC were collected prospectively and
before treatment. Information on patient demographics, body mass index, performance …

Clinical utility of the pretreatment glasgow prognostic score in patients with advanced inoperable non-small cell lung cancer.

EY Leung, HR Scott, DC McMillan - … for the Study of Lung Cancer, 2012 - europepmc.org
Methods The data of 261 patients with inoperable NSCLC were collected prospectively and
before treatment. Information on patient demographics, body mass index, performance …